Dr. Rafael Santana-Davila, MD

Claim this profile

Seattle Cancer Care Alliance

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
9 reported clinical trials
15 drugs studied

Area of expertise

1

Lung Cancer

Rafael Santana-Davila, MD has run 5 trials for Lung Cancer. Some of their research focus areas include:

Stage III
Stage II
Stage I
2

Non-Small Cell Lung Cancer

Rafael Santana-Davila, MD has run 3 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage III
Stage II
Stage I

Affiliated Hospitals

Image of trial facility.

Fred Hutchinson Cancer Research Center

Image of trial facility.

Cancer Care Northwest-Valley

More about Rafael Santana-Davila, MD

Clinical Trial Related

7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Rafael Santana-Davila, MD has experience with

  • Atezolizumab
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Biospecimen Collection
  • Crizotinib
  • Bomedemstat
  • Trabedersen (OT-101)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Rafael Santana-Davila, MD specialize in?

Is Rafael Santana-Davila, MD currently recruiting for clinical trials?

Are there any treatments that Rafael Santana-Davila, MD has studied deeply?

What is the best way to schedule an appointment with Rafael Santana-Davila, MD?

What is the office address of Rafael Santana-Davila, MD?

Is there any support for travel costs?